We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+22.47%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$968M
AUM Growth
+$147M
Cap. Flow
-$19.6M
Cap. Flow %
-2.03%
Top 10 Hldgs %
35.24%
Holding
253
New
24
Increased
29
Reduced
113
Closed
7

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.67M
2
QCOM icon
Qualcomm
QCOM
+$1.95M
3
AMZN icon
Amazon
AMZN
+$1.8M
4
OTIS icon
Otis Worldwide
OTIS
+$1.14M
5
CARR icon
Carrier Global
CARR
+$870K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$5.85M
2
BA icon
Boeing
BA
+$3.28M
3
JPM icon
JPMorgan Chase
JPM
+$2.64M
4
RTX icon
RTX Corp
RTX
+$2.48M
5
AAPL icon
Apple
AAPL
+$1.74M

Sector Composition

Rank Sector Weight
1 Healthcare 20.84%
2 Technology 19.89%
3 Financials 14.13%
4 Industrials 9.95%
5 Communication Services 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$339B
$11.8M 1.22%
98,470
-1,600
-2% -$187K
QCOM icon
27
Qualcomm
QCOM
$176B
$11.6M 1.2%
127,325
+24,255
+24% +$1.95M
UNH icon
28
UnitedHealth
UNH
$370B
$10.4M 1.08%
35,323
+1,120
+3% +$321K
BMY icon
29
Bristol-Myers Squibb
BMY
$132B
$10.1M 1.04%
171,938
-5,471
-3% -$327K
UNP icon
30
Union Pacific
UNP
$174B
$9.71M 1%
57,419
-909
-2% -$146K
J icon
31
Jacobs Solutions
J
$17B
$9.69M 1%
138,116
-4,117
-3% -$278K
BRK.B icon
32
Berkshire Hathaway Class B
BRK.B
$1.13T
$9.64M 1%
54,006
+841
+2% +$154K
BXMT icon
33
Blackstone Mortgage Trust
BXMT
$2.38B
$9.58M 0.99%
397,626
+67
+0% +$1.54K
HON icon
34
Honeywell
HON
$78B
$9.36M 0.97%
68,659
+1,327
+2% +$176K
ORCL icon
35
Oracle
ORCL
$423B
$8.66M 0.89%
156,721
-10,770
-6% -$571K
CRM icon
36
Salesforce
CRM
$158B
$8.57M 0.88%
45,726
PEP icon
37
PepsiCo
PEP
$190B
$8.47M 0.87%
64,041
+71
+0.1% +$9.36K
BP icon
38
BP
BP
$107B
$8.23M 0.85%
352,949
-1,750
-0.5% -$42K
IBB icon
39
iShares Biotechnology ETF
IBB
$9.77B
$8.09M 0.84%
59,161
-2,125
-3% -$271K
PWR icon
40
Quanta Services
PWR
$101B
$7.93M 0.82%
202,245
-37,295
-16% -$1.33M
VZ icon
41
Verizon
VZ
$196B
$7.91M 0.82%
143,502
+8,575
+6% +$482K
CVS icon
42
CVS Health
CVS
$122B
$7.64M 0.79%
117,545
+1,725
+1% +$109K
COST icon
43
Costco
COST
$420B
$7.37M 0.76%
24,290
+527
+2% +$160K
CVX icon
44
Chevron
CVX
$366B
$6.98M 0.72%
78,229
-5,879
-7% -$526K
EMR icon
45
Emerson Electric
EMR
$88.3B
$6.73M 0.7%
108,500
-441
-0.4% -$25.1K
AXP icon
46
American Express
AXP
$230B
$6.32M 0.65%
66,367
-1,921
-3% -$177K
GDX icon
47
VanEck Gold Miners ETF
GDX
$27.4B
$6.04M 0.62%
164,545
+12,970
+9% +$426K
IBM icon
48
IBM
IBM
$224B
$5.4M 0.56%
46,743
-318
-0.7% -$36.9K
ADP icon
49
Automatic Data Processing
ADP
$108B
$5.33M 0.55%
35,807
-240
-0.7% -$34.4K
RTX icon
50
RTX Corp
RTX
$301B
$5.3M 0.55%
85,943
-39,806
-32% -$2.48M

Similar funds

Neville Rodie & Shaw's Q2 2020 Portfolio in Review

As of Q2 2020, Neville Rodie & Shaw held 253 positions worth $968M, up 18% from $821M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Neville Rodie & Shaw's Q2 2020 filing shows 24 new, 29 increased, 113 reduced and 7 closed positions. Its largest new stake was Otis Worldwide: 22,089 shares worth $1.26M. The largest sale was Allergan plc, an estimated $5.85M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Neville Rodie & Shaw's largest Q2 2020 buy was Otis Worldwide: 22,089 shares worth $1.26M.
  • Neville Rodie & Shaw added most to AbbVie in Q2 2020, an estimated $2.67M increase.
  • Neville Rodie & Shaw's biggest Q2 2020 reduction was Boeing, cutting an estimated $3.28M.
  • Neville Rodie & Shaw fully exited Allergan plc in Q2 2020, selling an estimated $5.85M.
  • Neville Rodie & Shaw's ten largest holdings make up 35% of its $968M portfolio in Q2 2020.
  • Neville Rodie & Shaw opened 24 new positions and closed 7 in Q2 2020.
  • Neville Rodie & Shaw's portfolio value rose 18% quarter-over-quarter to $968M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2020, filed 15 Jul 2020.